Showing results (21-30 of 103) with videos related to
Sort By:
Pageof 11
Digestive Diseases and Sciences|September 23, 2016
B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel DiseasesMathieu Uzzan, Jean-Frederic Colombel, Andrea Cerutti, et al.Nature Reviews. Gastroenterology & Hepatology|December 19, 2013
IBD across the age spectrum: is it the same disease?Joannie Ruel, Darren Ruane, Saurabh Mehandru, et al.Mucosal Immunology|August 13, 2023
Understanding the molecular mechanisms of anti-trafficking therapies and their clinical relevance in inflammatory bowel diseaseSaurabh Mehandru, Jean-Frederic Colombel, Julius Juarez, et al.Inflammatory Bowel Diseases|January 26, 2016
Potential Immunomodulatory Effects of Statins in Inflammatory Bowel DiseaseJustin Côté-Daigneault, Saurabh Mehandru, Ryan Ungaro, et al.Lancet (London, England)|December 5, 2016
Ulcerative colitisRyan Ungaro, Saurabh Mehandru, Patrick B Allen, et al.Nature Reviews. Gastroenterology & Hepatology|April 20, 2023
The appendix and ulcerative colitis - an unsolved connectionManasi Agrawal, Kristine H Allin, Saurabh Mehandru, et al.AIDS Research and Human Retroviruses|April 1, 2023
Ex Vivo Colonic Tissue Susceptibility to HIV-1 in Cisgender Men and WomenPatrick Barnable, Sampurna Mukhopadhyay, Larisa Kizima, et al.Nature Reviews. Gastroenterology & Hepatology|November 10, 2023
Deciphering the different phases of preclinical inflammatory bowel diseaseJonas J Rudbaek, Manasi Agrawal, Joana Torres, et al.The American Journal of Gastroenterology|August 30, 2022
Early-Life Mebendazole Exposure Increases the Risk of Adult-Onset Ulcerative Colitis: A Population-Based Cohort StudyManasi Agrawal, Kristine H Allin, Aske T Iversen, et al.Annals of the New York Academy of Sciences|January 2, 2018
Efficient long-term depletion of CD20+ B cells by rituximab does not affect gut-resident plasma cellsMathieu Uzzan, Huaibin M Ko, Adam K Rosenstein, et al.Pageof 11